Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Provencio

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2019
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancerM Majem, J Hernández-Hernández, F Hernando-Trancho, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significanceR Gonzalez, J M Silva, A Sanchez, et al.
Revista Clinica Espanola|July 28, 2004
[Patient with double lung lesion and history of renal adenocarcinoma]E Carcereny Costa, M Provencio Pulla, R Cubedo Cervera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessaryM Provencio, A Sánchez, A Artal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 14, 2019
Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in SpainJ L Cruz-Bermúdez, C Parejo, F Martínez-Ruíz, et al.
The European Respiratory Journal|July 3, 2010
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalJ Silva, V García, Á Zaballos, et al.
ESMO Open|February 28, 2021
Small-cell lung cancer in never-smokersM Torres-Durán, M T Curiel-García, A Ruano-Ravina, et al.
Gut|November 25, 2003
Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancerJ M Garcia, R Rodriguez, G Dominguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 8, 2019
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancerM Majem, J Hernández-Hernández, F Hernando-Trancho, et al.
Cancer Epidemiology|March 14, 2015
Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON studyE Esteban, M Majem, M Martinez Aguillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significanceR Gonzalez, J M Silva, A Sanchez, et al.
Revista Clinica Espanola|July 28, 2004
[Patient with double lung lesion and history of renal adenocarcinoma]E Carcereny Costa, M Provencio Pulla, R Cubedo Cervera, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2013
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessaryM Provencio, A Sánchez, A Artal, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 14, 2019
Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in SpainJ L Cruz-Bermúdez, C Parejo, F Martínez-Ruíz, et al.
The European Respiratory Journal|July 3, 2010
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survivalJ Silva, V García, Á Zaballos, et al.
ESMO Open|February 28, 2021
Small-cell lung cancer in never-smokersM Torres-Durán, M T Curiel-García, A Ruano-Ravina, et al.
Gut|November 25, 2003
Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancerJ M Garcia, R Rodriguez, G Dominguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2018
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaW Jurczak, P L Zinzani, G Gaidano, et al.
Pageof 11